Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4228455
Max Phase: Preclinical
Molecular Formula: C14H10N6O
Molecular Weight: 278.27
Molecule Type: Small molecule
Associated Items:
ID: ALA4228455
Max Phase: Preclinical
Molecular Formula: C14H10N6O
Molecular Weight: 278.27
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=c1c(-c2cc[nH]n2)n[nH]c2c(-c3ccccc3)cnn12
Standard InChI: InChI=1S/C14H10N6O/c21-14-12(11-6-7-15-17-11)18-19-13-10(8-16-20(13)14)9-4-2-1-3-5-9/h1-8,19H,(H,15,17)
Standard InChI Key: ICYCWACHPRPMAN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 278.27 | Molecular Weight (Monoisotopic): 278.0916 | AlogP: 1.47 | #Rotatable Bonds: 2 |
Polar Surface Area: 91.73 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.29 | CX Basic pKa: 0.91 | CX LogP: 2.53 | CX LogD: 2.52 |
Aromatic Rings: 4 | Heavy Atoms: 21 | QED Weighted: 0.58 | Np Likeness Score: -1.45 |
1. Guerrini G, Ciciani G, Daniele S, Martini C, Costagli C, Guarino C, Selleri S.. (2018) A new class of pyrazolo[5,1-c][1,2,4]triazines as γ-aminobutyric type A (GABAA) receptor subtype ligand: synthesis and pharmacological evaluation., 26 (9): [PMID:29650463] [10.1016/j.bmc.2018.04.011] |
Source(1):